earnings
confidence high
sentiment positive
materiality 0.70
Pediatrix Q2 EPS $0.46, Adjusted $0.53; raises FY 2025 EBITDA guidance to $245-255M
Pediatrix Medical Group, Inc.
2025-Q2 EPS reported
$0.70
revenue$927,203,000
- Net revenue $469M; net income $39M vs. loss of $153M a year ago due to non-cash impairment.
- Adjusted EBITDA $73M, up from $58M in Q2 2024; raised FY guidance to $245-255M (from $220-240M).
- Same-unit revenue +6.4% with neonatology NICU days up 6.0% year-over-year.
- Cash from continuing operations $138M; total debt $606M; no revolver borrowings.